Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,822 | Dovepress* | 8,176+ | 897 | 9,073 | |
PubMed Central* | 646 | 162 | 808 | ||
Totals | 8,822 | 1,059 | 9,881 | ||
*Since 25 June 2018 |
View citations on PubMed Central and Google Scholar